The Tech Company That The Cannabis Industry Has Been Waiting For
Interview with Edward Klaeger IV, CEO of Fiberlab Inc.
According to an interview with Edward Klaeger, the supply of separated cannabinoids in bulk quantities is the market‘s bottleneck:
“The problem with the medical and pharmaceutical markets in the cannabinoid industry: There is no bulk separation of cannabinoids to mass produce a prescription – and that’s where Fiberlab comes in.“
“The economies of scale is what sets Fiberlab technology apart and then the fact that we can create bulk isolation of cannabinoids.“
“We can give you a CBDA stream, or THCA stream, completely pure and clean, which you can then crystallize, or you can keep it as an isolated concentrate, which is ideal for the medical and pharmaceutical market, because then you can micro-dose for compounding, for prescriptions or diagnosis.“
“We don’t heat any cannabinoids, so our model is based around zero molecular destruction. We maintain the integrity of the whole plant material. We deliver cannabinoids the way nature intended them to be. We use cold-press, cold-filtered extraction – no heat and no pressure in our process.“
Rockstone is a research house specialized in the analysis and valuation of capital markets and publicly listed companies. The focus is set on exploration, development and production of resource deposits as well as marcoeconomic analysis of commodity and currency markets. Our international team of five analysts bring our German and English speaking readership a wealth of experience from the commodity markets: Stephan Bogner (mining analyst), John P. Barry (professional geologist), Chris Berry (macroeconomist), Prof. Dr. Hans Bocker (award-winning book author), and Boris Gerjovic (fundamental analyst).
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.